Sanofi American Depositary Shares (Each representing one-half of one ordinary share) (SNY) Financials
Key financial figures for Sanofi American Depositary Shares (Each representing one-half of one ordinary share) (Q2 2026), as reported in EUR.
Sanofi reported revenue of 12.30 billion EUR for Q2 FY2026, up 14.6% from the same period a year earlier. Net income was 343.0 million EUR, or 0.14 EUR per share. Operating margin came to 19.38%, against 13.73% a year earlier. Free cash flow for the period was 3.90 billion EUR. Across the last 5 reported quarters, quarterly revenue has risen from 10.74 billion EUR in Q2 FY2025 to 12.30 billion EUR in Q2 FY2026. The figures above are as filed, and the full income statement, balance sheet and cash flow history for Sanofi are on the SentiSense financials page.
- Revenue
- EUR 12.3B
- Net Income
- EUR 343M
- EPS
- EUR 0.14
- Total Assets
- EUR 129.1B
- Operating Cash Flow
- EUR 5.4B
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q2 FY2026 | EUR 12.3B | EUR 343M | EUR 0.14 | 19.38% | EUR 3.9B |
| Q1 FY2026 | EUR 11.2B | EUR 1.6B | EUR 0.67 | 20.18% | EUR 1.7B |
| Q4 FY2025 | EUR 12.2B | -EUR 801M | -EUR 1.46 | -8.5% | EUR 1.6B |
| Q3 FY2025 | EUR 13.2B | EUR 2.8B | EUR 1.14 | 27.51% | |
| Q2 FY2025 | EUR 10.7B | EUR 3.9B | EUR 1.60 | 13.73% | EUR 0 |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | EUR 46.7B | EUR 7.8B | EUR 3.20 | 20.54% | EUR 10.1B |
| FY2024 | EUR 44.3B | EUR 5.6B | EUR 2.19 | 16.38% | EUR 5.9B |
| FY2023 | EUR 41.6B | EUR 5.4B | EUR 2.15 | 16.72% | EUR 7.4B |
Frequently asked questions
What was Sanofi's revenue last quarter?
Sanofi reported revenue of 12.30 billion EUR for Q2 FY2026, up 14.6% from the same period a year earlier.
Is Sanofi profitable?
Yes. Sanofi reported net income of 343.0 million EUR for Q2 FY2026, a net margin of 2.79% on revenue.
How has Sanofi's margin trended?
Operating margin was 19.38% in Q2 FY2026, compared with 13.73% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did Sanofi generate?
Sanofi generated free cash flow of 3.90 billion EUR in Q2 FY2026, after capital expenditure.
Figures are as reported by the filer in EUR and are not converted to US dollars. The share price is quoted in US dollars, so the two are not directly comparable.
Full income statement, balance sheet and cash flow for Sanofi American Depositary Shares (Each representing one-half of one ordinary share) on SentiSense, with up to forty quarters and twenty fiscal years of history.